Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qian Chu

Showing results (61-70 of 306) with videos related to

Pageof 31
Sort By:
Experimental Hematology & Oncology|December 12, 2018
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicineHanxiao Xu, Ying Jiao, Shuang Qin, et al.
Frontiers in Oncology|September 23, 2021
Biomarkers and Future Perspectives for Hepatocellular Carcinoma ImmunotherapyYuqing He, Mengyao Lu, Jing Che, et al.
Frontiers in Bioscience (Landmark Edition)|October 11, 2025
Diagnostic Value of <i>CDO1</i> Promoter Methylation in Lung Cancer via Liquid Biopsy: A Systematic Review and Meta-AnalysisYuheng Yan, Ziyang Xu, Fangfang Liu, et al.
Analytical Chemistry|June 10, 2026
Organelle-Specific Interactome Mapping via Enzyme-Responsive Cross-Linking and Proximity LabelingXuechun Yuan, Kai Li, Zifan Wang, et al.
Molecular Cancer|February 20, 2018
EGFR-TKIs resistance via EGFR-independent signaling pathwaysQian Liu, Shengnan Yu, Weiheng Zhao, et al.
Journal of Hematology & Oncology|June 10, 2020
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017Ming Yi, Anping Li, Linghui Zhou, et al.
Medicine|May 9, 2020
PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancerLiya Hu, Peng Zhang, Wei Sun, et al.
American Journal of Cancer Research|October 20, 2025
Proteomic landscape of lung adenocarcinoma precancerous lesions reveals mitochondrial dsRNA-associated immune and stress responsesXizhen Xu, Tianqi Gong, Zitian Huo, et al.
Integrative Cancer Therapies|September 14, 2019
Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer ImmunotherapyMing Yi, Dechao Jiao, Shuang Qin, et al.
Molecular Cancer|March 31, 2019
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatmentMing Yi, Dechao Jiao, Shuang Qin, et al.
Pageof 31

Showing results (61-70 of 306) with videos related to

Sort By:
Pageof 31
Experimental Hematology & Oncology|December 12, 2018
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicineHanxiao Xu, Ying Jiao, Shuang Qin, et al.
Frontiers in Oncology|September 23, 2021
Biomarkers and Future Perspectives for Hepatocellular Carcinoma ImmunotherapyYuqing He, Mengyao Lu, Jing Che, et al.
Frontiers in Bioscience (Landmark Edition)|October 11, 2025
Diagnostic Value of <i>CDO1</i> Promoter Methylation in Lung Cancer via Liquid Biopsy: A Systematic Review and Meta-AnalysisYuheng Yan, Ziyang Xu, Fangfang Liu, et al.
Analytical Chemistry|June 10, 2026
Organelle-Specific Interactome Mapping via Enzyme-Responsive Cross-Linking and Proximity LabelingXuechun Yuan, Kai Li, Zifan Wang, et al.
Molecular Cancer|February 20, 2018
EGFR-TKIs resistance via EGFR-independent signaling pathwaysQian Liu, Shengnan Yu, Weiheng Zhao, et al.
Journal of Hematology & Oncology|June 10, 2020
The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017Ming Yi, Anping Li, Linghui Zhou, et al.
Medicine|May 9, 2020
PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancerLiya Hu, Peng Zhang, Wei Sun, et al.
American Journal of Cancer Research|October 20, 2025
Proteomic landscape of lung adenocarcinoma precancerous lesions reveals mitochondrial dsRNA-associated immune and stress responsesXizhen Xu, Tianqi Gong, Zitian Huo, et al.
Integrative Cancer Therapies|September 14, 2019
Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer ImmunotherapyMing Yi, Dechao Jiao, Shuang Qin, et al.
Molecular Cancer|March 31, 2019
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatmentMing Yi, Dechao Jiao, Shuang Qin, et al.
Pageof 31